Science Policy and Government Affairs Committee

Printer-friendly version

Kenneth C. Anderson, MD
Program Director and Chief, Division of Hematologic Neoplasia
Kraft Family Professor of Medicine
Harvard Medical School, Dana-Farber Cancer Institute
Boston, Massachusetts

Anna D. Barker, PhD
Chief Strategy Officer
Ellison Institute for Transformative Medicine
Los Angeles, California

Michael J. Birrer, MD, PhD
Director
Winthrop P. Rockefeller Cancer Institute
Bronx, New York

Mark E. Burkard, MD, PhD
Director
Holden Comprehensive Cancer Center
Iowa City, Iowa

Bradley R. Cairns, PhD
Professor and Chair
University of Utah, Huntsman Cancer Institute
Salt Lake City, Utah

John L. Cleveland, PhD
Executive Vice President, Center Director, and Chief Scientific Officer
Moffitt Cancer Center
Tampa, Florida

Benjamin F. Cravatt, PhD
Professor
The Scripps Research Institute
La Jolla, California

Robert S. DiPaola
Provost
University of Kentucky
Lexington, Kentucky

Marvella Elizabeth Ford, PhD
Professor, Endowed Chair, Cancer Disparities
Medical University of South Carolina
Charleston, South Carolina

Roy A. Jensen
Director
The University of Kansas Cancer Center
Kansas City, Kansas

Peter A. Jones, PhD, DSc, FAACR
President and Chief Scientific Officer
Van Andel Research Institute
Grand Rapids, Michigan

Jan Kitajewski, PhD
Professor and Head
Department of Physiology and Biophysics
University of Illinois Cancer Center
Chicago, Illinois

Suchitra Krishnan-Sarin, PhD
Albert E. Kent Professor of Psychiatry
Yale School of Medicine
New Haven, Connecticut

Ming Lei, PhD
Sr. Associate Vice President, Health Sciences Center
West Virginia University
Morgantown, West Virginia

Steven K. Libutti, MD, FACS
Director
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey

Christine M. Lovly, MD, PhD
Associate Professor of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Crystal L. Mackall, MD, FAACR
Founding Director
Stanford Center for Cancer Cell Therapy
Stanford, California

Ira Mellman, PhD, FAACR
Professor, Department of Biochemistry and Biophysics
San Francisco School of Medicine
San Francisco, California

Lucio Miele, MD, PhD
Professor and Head, Department of Genetics
LSU Health Sciences Center
New Orleans, Louisiana

Gilbert S. Omenn, MD, PhD
Harold T Shapiro Distinguished University Professor of Medicine
University of Michigan Medical School
Ann Arbor, Michigan

Karolina Palucka, MD, PhD
Professor, Director
The JAX Cancer Center
Jacksonville, Florida

Charles M. Perou, PhD, FAACR
Professor, Department of Genetics
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina

Joe W. Ramos, PhD
President and CEO
The Lundquist Institute
Torrance, California

Dorothy Rhoades, MD, MPH
Clinical Professor of Medicine
University of Medicine, The University of Oklahoma Health Sciences
Oklahoma City, Oklahoma

Brian M. Rivers, PhD
Director
Cancer Health Equity Institute Director Morehouse School of Medicine
Atlanta, Georgia

Gary K. Schwartz, MD
Director
Case Comprehensive Cancer Center
Cleveland, Ohio

Ellen V. Sigal, PhD
Chairperson and Founder
Friends of Cancer Research
Washington, District of Columbia

Barry P. Sleckman, MD, PhD
Director
UAB O’Neal Comprehensive Cancer Center
Birmingham, Alabama

Sheila A. Stewart, PhD
Professor, Cell Biology and Physiology
Washington University School of Medicine
St. Louis, Missouri

Elizabeth M. Swisher, MD
Deputy Director
Fred Hutch Cancer Center
Seattle, Washington

Robert H. Vonderheide, MD, PhD
Director
Penn Medicine Abramson Cancer Center
Philadelphia, Pennsylvania

E. John Wherry III
Chair, Department of Systems
Perelman School of Medicine
Philadelphia, Pennsylvania

Cheryl L. Willman, MD
Executive Director
Mayo Clinic Comprehensive Cancer Center
Rochester, Minnesota

Robert A. Winn, MD
Director
VCU Massey Comprehensive Cancer Center
Richmond, Virginia

Jedd D. Wolchok, MD, PhD, FAACR
Director
Sandra and Edward Meyer Cancer Center
Weill Cornell Medicine
New York, New York

Wendy A. Woodward, MD, PhD
Professor, Chair, Department of Breast Radiation Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

Patricia M. LoRusso, DO, PhD (hc), FAACR
AACR President, 2024-2025
Amy and Joseph Perella Professor of Medicine, Professor and Director
Yale School of Medicine
New Haven, Connecticut

Lillian L. Siu, MD, FAACR
AACR President-elect, 2024-2025
Director, Phase I Clinical Trials Program
University of Toronto
Toronto, Canada

Keith T. Flaherty, MD, FAACR
AACR President-elect, 2025-2026
Director of Clinical Research
Mass General Cancer Center
Boston, Massachusetts

AACR CONTACT

Carly McCallie
Director, Government Affairs
Email